Central mucoepidermoid carcinoma: An up-to-date analysis of 147 cases and review of prognostic factors.
J Craniomaxillofac Surg 2017;
46:162-167. [PMID:
29198377 DOI:
10.1016/j.jcms.2017.10.020]
[Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2017] [Revised: 09/26/2017] [Accepted: 10/24/2017] [Indexed: 11/22/2022] Open
Abstract
OBJECTIVE
To integrate the available data published on central mucoepidermoid carcinoma (CMC) into a comprehensive analysis of its clinical aspects, histology, treatment, and prognostic factors.
METHODS
An electronic search was undertaken in July 2017. Eligibility criteria for publications included having clinical, histological, treatment, and time of follow-up data to confirm the diagnosis.
RESULTS
In addition, gender, histological grade, conservative treatment, and lymph node metastasis were significant independent prognostic factors.
CONCLUSION
Male patients with histological grade III CMC of the jaw bone, who used conservative treatment as the main treatment, and presented with lymph node metastasis, were more likely to have a worse prognosis.
Collapse